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Several phenotypes related to well-being (e.g., life satisfaction, positive affect, neuroticism, and depressive symptoms), are genetically highly correlated (| r g | > .75). Multivariate analyses of these traits, collectively referred to as the well-being spectrum, reveals 24 genome-wide significant loci. We integrated the genetic findings with large human transcriptome and epigenome datasets. Integrated analyses implicate gene expression at 48 additional loci and CpG methylation at 28 additional loci in the etiology of well-being.
Well-being plays an important role in economics, psychology, and medicine 1, 2 . Well-being owes it interdisciplinary prominence to its associations with physical and mental health, and its role as a desired socio-economic outcome and index of economic development 3 . Most existing research on behavioral traits is characterized by a focus on a single phenotype, despite the strong correlations between related traits.
The high genetic correlations (| r g | > .75) 4 between life satisfaction, positive affect, neuroticism, and depressive symptoms suggest a common liability. We performed a multivariate genome-wide metaanalysis (multivariate GWAMA) (N= 584, 302) of these four phenotypes to increase the power to identify associated genetic variants (Supplementary Table 1 ).
Our analyses leveraged publically available univariate GWAMA 4 dependence between effect sizes (error correlation), induced by sample overlap, was estimated from genome-wide summary statistics obtained from univariate GWAMA (http://www.thessgac.org) using LD score regression (see online methods). Knowledge of the error correlation between univariate metaanalyses allowed otherwise unused (dependent) samples to be meta-analyzed, providing a gain in power while guarding against inflated type I error rates (see online methods).
We recognize that the measures included in the well-being spectrum are not necessarily interchangeable.
Therefore, we performed two types of multivariate GWAMA; 1) N-weighted multivariate GWAMA, which assumes a single underlying construct (see online methods); 2) A model-average GWAMA, where we relaxed the assumption of a unitary effect of the SNP on all traits. For the latter analyses, we performed eight model-based GWAMA´s, capturing various combinations of SNP effects (see online methods). To account for within and between model variability, we took a weighted average of the effect size and standard error for each SNP, across the eight models. For each of the eight models we computed an AICc weight to ensure that all models are weighted properly 5 . The two multivariate analysis methods, we developed, can cope with multiple traits, repeated measures, and can be applied to cohort level and meta-analysis summary statistics. The model average GWAMA can further accommodate existing multivariate GWAMA techniques and models. Together these techniques are excellent future proof tools for analysis in a field where sample overlap is complex to track and large existing GWAMA projects need to be integrated with massive novel data sources.
In our N-weighted multivariate GWAMA * , we identified 16 significant loci (Fig. 1A) . Ten of these loci have not previously been associated with any of the traits 4 . Twelve loci, which were identified in previous Figure 1 . Panel A contains a Manhattan plot where the -log 10 (P-value) obtained from our N-weighted GWAMA of a SNP effect on life satisfaction, positive affect, neuroticism, and depressive symptoms is plotted against the genomic location for the SNP. Panel B contains four Manhattan plots, these are obtained from our model averaging GWAMA, where a series of models is fit to GWAMA summary statistics for life satisfaction, positive affect, neuroticism, and depressive symptoms, and the SNP effect is evaluated with respect to each of the four outcomes.
To confirm the gain in power of our multivariate GWAMA results, we performed polygenic risk score prediction (PRS) in two independent samples (online methods). We predicted the phenotypes in the wellbeing spectrum (life satisfaction, positive affect, neuroticism, and depressive symptoms). The combined PRS based on the N-weighted GWAMA improved prediction with an average increase in R 2 of 0.36 (1. We searched the HGRI-EBI catalog 6 of published genome-wide association studies (GWAS catalog) for genes located near loci associated with well-being in order to identify pleiotropic effects ( Supplementary   Fig. 2 ). In total, we found 113 genes within a 250kb distance of the independent loci, of which 47 genes were previously reported in other studies. Of these 47 genes, a substantial number (40.4%) is previously associated with neuropsychiatric traits, followed by immune disease (12.7%), and drug response associations (12.7%). For a complete overview, see Supplementary Table 10 .
Both multivariate GWAMAs aggregated the effect of a single SNP across multiple traits based on prior knowledge of the genetic correlation between these traits. In a similar fashion, we proceeded to aggregate the effect across multiple SNPs based on prior knowledge that these SNPs collectively influence the We searched the GWAS catalog 6 for both our TWAS and MWAS hits that did not reach genome-wide significance in the GWAMA analyses (>500kb distance, Supplementary Fig. 2 ). Based on TWAS, we found 48 genes, of which 28 genes were previously associated with other traits. Of these 28 genes, 39%
were associated with biochemical markers, 32% were associated with neuropsychiatric traits, and 28.6%
with anthropometric features. Based on MWAS, 28 genes were located near 44 CpG sites. Of these 28 genes, 18 were previously associated with other traits, 66% of these were associated with neuropsychiatric or neuropsychiatric drug response, 50% were associated without otherwise specified diseases or traits, and 38.9% were associated with biochemical markers. The strong pleiotropy with neuropsychiatric traits, strengthens our confidence that the loci found in TWAS and/or MWAS results are valid well-being spectrum loci. A complete overview is provided in Supplementary Table 16-17.
Four loci are associated with well-being in all three GWAMA, TWAS and MWAS analyses, which suggests a role for both gene expression and CpG methylation at these loci in well-being, or possible mediation of the relation between gene expression and well-being by CpG methylation ( Supplementary   Fig. 3-4) . The locus at chromosome 6 within the MHC region is of special interest. Recent work has identified 3 individual signals related to schizophrenia in the MHC region, one of which is linked to complement 4 (C4A) gene expression and synapse elimination during puberty 13 . The genome-wide significant signal for well-being in the MHC region is not in strong LD with lead eQTL's for C4A gene expression. Rather a second independent signal tagged by rs13194504 is associated with both schizophrenia and well-being. TWAS and MWAS results for the MHC region implicate the expression of ZKSCAN4 and methylation of cg08798685 in the etiology of well-being.
We performed further biological annotation using LD score regression (Supplementary Table 18 ). Our analyses revealed significant enrichment of SNP effects in regions of the genome characterized by active histone marks in the following brain tissues: fetal brain tissue, the germinal matrix (a highly cellular and highly vascularized region in the brain from which cells migrate out during brain development), the midfrontal lobe, inferior temporal lobe, angular gyrus, middle hippocampus, cingulate gyrus, and anterior caudate ( Supplementary Fig. 5 ). We found further enrichment of SNP effects in a single endocrine tissue, specifically the Thymus. Note that endocrine tissue that is more frequently implicated in depression (e.g., the thyroid and pituitary) were not tested. Further analysis using LD score regression, where the LD scores are based on evolutionary markers 14 , revealed that SNPs of very recent origin (i.e. a low allelic age) explained substantially more variation than ancient SNPs (Supplementary Table 19 and Supplementary   Fig. 6 ). These findings indicate the presence of negative selection shaping variation in well-being through recent evolution (see online methods).
In summary, previous univariate analyses of phenotypes in the well-being spectrum were moderately successful. Our analysis gained power through multivariate GWAMA and we identified novel loci associated with well-being. Model averaging GWAMA identified additional loci, associated with some but not all traits in the well-being spectrum, and provided flexibility in terms of model specification.
Model averaging can in fact incorporate any multivariate GWAMA or GWAS model for which the per SNP model fit can be expressed in terms of an AICc fit statistic. The averaging procedure is done per locus, allowing for heterogeneity across phenotype and loci. The model averaging procedure is not limited to analyses of multiple GWAMA but can in fact be applied to tackle heterogeneity between individual cohorts in GWAMA. We found that TWAS and MWAS can yet further increase the pool of loci related to variation in complex traits, like well-being. These analyses would not have been possible were it not for good scientific practice of openly sharing summary level data. We foresee multivariate GWAMA will play an important role in the ongoing discussion on the boundaries of the set of phenotypes, which define "well-being", or more narrowly in studying heterogeneity in the psychiatrically relevant subset of traits or symptoms, which pertain to "depression". We propose model averaging as an agnostic approach, which enables the use of a very broad phenotype definition and gives researchers the explicit choice of considering multiple multivariate models, maximizing power for locus discovery while retaining the ability to detect trait specific effects.
Online Methods

N-weighted multivariate GWAMA.
We obtained summary statistics from previous analyses in Okbay et al. 4 , where multiple cohorts contributed to the univariate GWAMAs of life satisfaction, positive affect, neuroticism and depressive symptoms http://www.thessgac.org/. To quantify the dependence between the univariate GWAMAs, we estimated the cross trait LD score intercept (CTI) 15, 16 .
Where N s equals the sample overlap, N 1 the sample size for trait one and N 2 the sample size for trait two, equals the phenotypic correlation between trait one and two. The CTI is approximately equal to the covariance between the test statistics obtained in a GWAMA of trait 1 and trait 2. We assume the estimated CTI is equal to the true CTI, though note the uncertainty in the estimated CTI is generally low.
Given the estimated covariance between effect sizes we can meta-analyse the four dependent GWAMAs and obtain a multivariate test statistic per SNP:
Where w ik is the square root of the sample size for SNP k in the GWAMA of trait i, Z ik is the test statistics of SNP k in the GWAMA of trait i; V ik is the variance of the test statistic for SNP k in the GWAMA of trait i (i.e 1 given that Z is a standardized test statistic) and C i,j,k is the covariance between test statistics for SNP k between GWAMA of trait i and trait j (where C equals CTI obtained from cross trait LD score regression between trait i and trait j). The multivariate test statistic Ζ , is a standardized sum of tests statistics all of which follow a normal distribution under their respective null distributions, the statistic Ζ follows a standard normal distribution under the null hypothesis of no effect.
Model averaging GWAMA
Consider the following model:
Where (1xn) In this context, a regular GWAMA restricts the design matrix X to a unit vector (i.e. we model a single genetic effect, which is assumed identical across cohorts, and any observed variation is attributed to sample fluctuation). Generally, matrix V is diagonal, and contains the squared standard errors of elements in . A regular GWAMA is the most restricted model one can consider. However, when considering multivariate GWAMA (i.e. the elements in β reflect SNP effects on separate yet correlated phenotypes) this model might be too restrictive even when traits have a substantial genetic correlation, not all genetic effects need to be shared between traits or be identical in magnitude. The least restrictive model is to consider the SNP effects in independent (i.e. run univariate GWAMA of the correlated phenotypes). In between the most restrictive and least restrictive model, a manifold of models can be specified, equating the effects in y across combinations of traits, while allowing it to differ between other combinations of traits. These models can be specified by ways of the design matrix X.
One could consider a manifold (z) of models (m), each with a different design matrix X. 
For each AICc we compute the delta (Δ m ) to the best (i.e lowest) AICc value, and from these we compute the model weights (g) for the k models as:
We predict the vector β using each of the models
̂=
One can aggregate the prediction over all models as:
And we aggregate the uncertainty within and between models to obtain ( ):
The resulting vector contains the model averaged effect sizes for the effect of a particular SNP on the phenotypes subjected to multivariate analysis. Note how the variance estimate contains a variance component which reflects within model variability (var(̂)) which equals the square of the standard error, and a variance component between model variability ((̂− ̅ ) 2 ) in estimate, which ensures no overfitting occurs.
Our procedure boosts power if the SNP effect is concordant between traits, while retaining strongly discordant SNP effects if the model favors these. Model averaging offers several avenues for extension.
One can constrain the SNP effects across multiple SNPs based on biological knowledge of the relation between the SNPs and gene expression, or CpG methylation (analog to TWAS). Alternative it might be beneficial to average the AICc weights across regions of the genome. Model averaging can in principle accommodate any model for which the AICc information criterion can be expressed. These models should result in a vector of SNPS effects ( ) and an asymptotic variance for the SNP effects. In the current application, models per SNP are estimated in R using the "metafor" package and models are averaged using the "AICcmodavg" package 18, 19 .
Polygenic Risk Prediction
To confirm the gain in power of our multivariate GWAMA results, we perform polygenic risk score prediction (PRS) in two independent samples; 1) the Netherlands Twin Register (NTR) 20, 21 and Understanding Society (UKHLS) 22 . We predict the phenotypes in the well-being spectrum (life satisfaction, positive affect, neuroticism, and depressive symptoms). In NTR, LS and PA data are available in 9,143 and 6,836 genotyped participants. LS is measured longitudinally using the Satisfaction with Life Scale consisting of five items (e.g., "My life is going more or less as I wanted") with responses given on a seven-point scale, resulting in a minimum score of five and a maximum score of 35 23 . PA is also measured longitudinally using four questions that were adapted from the Subjective Happiness Scale 24 (e.g., "On the whole, I am a happy person") with responses on a seven-point scale, resulting in a minimum score of four and a maximum score of 28. Neuroticism data are available for 8,527 genotyped participants. The Big Five personality traits (including neuroticism) were measured by using the NEO-FFI 25 , a sixty-item personality questionnaire consisting of five subscales: neuroticism, extraversion, openness, agreeableness and conscientiousness. The responses were given on a five-point scale (0-4).
Subscale scores are constructed for each time point by taking the sum across the twelve subscale-specific items (after recoding opposite-stated items), and are set to missing if ten or more items of the total scale are unanswered. When subjects have fewer than ten missing items, missing items are scored at two (which is neutral given the 0-4 scale). Depressive symptoms are obtained from the DSM-oriented Depression subscale of the age-appropriate survey from the ASEBA taxonomy 26 and are available in 7,898
participants. To measure depressive symptoms, fourteen questions are used (e.g., "Enjoys little ") and responses were given on a three-point scale ranging from zero ("not true") to two ("very true"). The DSMoriented subscale is constructed for each time point by taking the sum across the fourteen subscalespecific items and is set to missing if more than twenty percent of the total survey items were unanswered.
When less than twenty percent of items are missing for a participant, the missing items are replaced by the participant's mean score.
In UKHLS data are available in 9,944 participants genotyped on the Illumina Human Core Exome
Beadchip. LS was measured longitudinally (waves 1-6). Participants were asked how satisfied they were "with life overall" with responses given on a seven-point scale, resulting in a minimum score of one and a maximum score of seven. PA is also measured longitudinally (waves 1 and 4 only) using The WarwickEdinburgh Mental Well-being scale (WEMWBS). SWEMWBS is a shortened version of WEMWBS. This and call rate < 0.98 were removed, individuals with A B and C were removed In NTR 1,224,793 SNPs passed QC and were used to construct polygenic scores and in UKHLS 955,441 SNPs passed QC and were used to construct polygenic scores. The phenotypes were regressed on sex, age as well as principal components which were included to correct for ancestry and the polygenic scores. Results can be found at Supplemental Table 11 .
Summary-Based transcriptome wide (TWAS) and methylome wide (MWAS) association studies
We used the tool DIST 27 to impute the HapMap reference based results for the N-weighted GWAMA to the 1000Genomes Phase1 reference. We aggregate SNP effects informed by their common effect on expression level of gene or CpG methylation, as was proposed by Gusev et al. 7 We used the BIOS eQTL resource as eQTL reference set to build imputation models to predict gene expression using multiple eQTL SNPs 9 . Models are built per gene (gene models) by identifying independent eQTL SNPs based on stepwise conditional regression. 9 The z-score for each eQTL SNP is used in TWAS as a weight (q).The eQTLs used are available at http://genenetwork.nl/biosqtlbrowser/. Based on the gene models, N-weighted GWAMA summary statistics and LD based on the GONL reference 28 , TWAS is performed. That is, for each gene-prediction-model containing eQTLs S 1 -S N with weights q=q 1, q 2 ,...,q n , the corresponding GWAMA z-scores z=z 1, z 2 ,...,z n and LD is an n-by-n correlation matrix for eQTLs S 1 -S N , were used to construct a test statistic:
√q * LD * q MWAS was performed following the same procedure to build imputation models to predict CpG site methylation of the DNA strand using multiple mQTL SNPs. The methylation site specific weights were obtained from the BIOS mQTL study 10 .
Reverse Causation testing
TWAS or MWAS imply an effect of gene expression or CpG site on the trait. 7 To rule out reverse causation where variation in the well-being spectrum influence gene expression or CpG site methylation, we apply the following algorithm. We compute 22 PRS based on the N-Weighted GWAMA using NTR as holdout cohort. In each of these 22 PRS we omit one of the 22 chromosomes and predict the CpG site and gene transcript located on that particular chromosome. For instance, at chromosome 1, our MWAS analyses yielded out 8 CpG sites. Then with our PRS omitting chromosome 1, we try to predict these 8
CpG sites. If this prediction results in significant beta coefficients, reverse causation cannot be ruled out.
For our prediction protocol, we standardize the PRS as well as the TWAS counts and CpG sites. To account for relatedness in NTR, generalized estimation equation (GEE) is used. 29 In TWAS prediction, we use sex, age at blood sampling, smoking, height, weight, plate and appropriate PCs as covariates. In MWAS prediction, we use sex, age at DNA blood sampling, array row number, smoking, eosinophils, -monocytes and neutrophils percentages as well as the appropriate PCs. To overcome the multiple testing burden, we use Bonferroni correction. For MWAS, significance was set at p < 0.00026 and for TWAS at p < 0.001. Results are displayed in Supplementary Tables 14-15 .
GWAS Catalog lookup
We search the NHGI GWAS catalog 6 to determine which of our genome-wide significant GWAMA, MWAS, and TWAS markers have been previously reported (database searched on 18-02-2017). We apply two strategies; 1) for our GWAMA analyses, we identify genes that are within a 250kb distance from a genome wide significant SNPs For our TWAS and MWAS analyses the focus is specifically on markers that were not significant in GWAMA analyses. Therefore, we rule out any genes that we identify in TWAS or near MWAS hits that are within 500kb distance from a GWAMA lead SNP. Gene transcripts and genes near CpG sites which conform to the criteria outlined above are looked up in the GWAS catalog. Results can be found in Supplementary Table 10 , 16-17.
Stratified LD score regression
To determine whether specific genomic regions are enriched for genetic effects on the well-being spectrum phenotypes, we used LD Score regression 15, 16 . We are specifically interested in regions of the genome which are histone modified in a specific tissue. For example, regions of the genome which are histone modified in the prefrontal cortex, can be transcribed more frequently in prefrontal tissue. The enrichment of these genomic regions in their effect on well-being suggest the involvement of processes in the prefrontal cortex in the etiology of wellbeing.
LD Score regression is based on the relationship between the observed chi-square of a SNP and the degree of LD between a SNP and its neighbor. SNPs in strong LD are more likely to tag causal effects on complex traits and therefore have a higher expected chi-square. The procedure can be extended to stratified LD score regression where multiple LD scores are created, each of which captures the LD for a SNP with other SNPs of a specific category of interest, for example SNPs in a histone modified region of the genome.
We follow the exact procedure described by Finucane et al. 30 We estimated stratified LD Score regression Supplementary Table 18 .
Stratified LD score regression to detect negative selection
Using LD score regression, where the LD scores are based on evolutionary markers, we test whether negative selection is present in shaping variation in the well-being spectrum through recent evolution. We use the same procedure as extensively described by Gazal et al. 14 
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